Company: LGNZZ
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000886163-25-000012
Chunk: 97

Company: LIGAND PHARMACEUTICALS INC
Filing Date: 2025-02-28
Form: 10-K
Item: Item 15
Chunk 97
---
93November 19, 20103.13.5Certificate of Amendment of the Amended and Restated Certification of Incorporation of the Company, dated June 19, 2018S-8333-233130August 8, 20193.63.6Fifth Amended and Restated Bylaws of the Company8-K001-33093April 19, 20243.14.1Specimen stock certificate for shares of the common stock of the Company10-K001-33093March 1, 20184.14.2Description of Registered Securities10-K001-33093February 24, 20214.310.1#2002 Stock Incentive Plan (as amended and restated effective June 10, 2022)DEF 14A001-33093April 22, 2022Appendix A10.2#2002 Employee Stock Purchase Plan (as amended and restated effective June 6, 2019)DEF001-33093April 24, 2019Appendix B

104

10.3#Form of Stock Option Grant Notice and Stock Option Agreement under the Company’s 2002 Stock Incentive Plan10-K001-33093February 24, 201410.510.4#Form of Stock Issuance Agreement for non-employee directors under the Company’s 2002 Stock Incentive PlanS-1333-131029January 13, 200610.28910.5#Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under the Company’s 2002 Stock Incentive Plan 10-K001-33093March 1, 201810.610.6#Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under the Company’s 2002 Stock Incentive Plan - Performance-Based RSU Form10-K001-33093March 1, 201810.710.7#Form of Executive Officer Change in Control Severance Agreement 8-K001-33093August 22, 200710.110.8#Form of Change in Control Severance Agreement10-Q001-33093May 8, 202310.310.9#Amended and Restated Severance Plan, effective November 1, 202210-K001-33093February 28, 202310.810.10#Director Compensation and Stock Ownership Policy, as amended and restated, effective August 4, 202310-Q001-